Topical Drugs- IVRT [Regulatives / Guidelines]

posted by MaggieSantos – Portugal, 2018-07-03 18:41 (880 d 18:19 ago) – Posting: # 19015
Views: 857


Regarding the new draft guidance on acyclovir ointment I have performed an IVRT test to compare the test and reference formulations. I used a Hanson system similar to the ones used for acyclovir creams.

During the validation of the test system, I applied the described parameters on draft guidance for acyclovir cream, namely, IVRT Discrimination Sensitivity, Specificity and Selectivity.

When comparing the lower (2.5%) and upper (7.5%) release rates to the 5% acyclovir ointment (PEG basis), the release rates were nor discriminatory.

As anyone performed this test, what results were obtained and what is the suggested reason for no discriminatory results. What is the impact?:confused:

Kind Regards


Complete thread:

 Admin contact
21,223 posts in 4,427 threads, 1,481 registered users;
online 25 (2 registered, 23 guests [including 15 identified bots]).
Forum time: Monday 12:01 CET (Europe/Vienna)

It’s difficult to work in a group
when you are omnipotent.    John de Lancie (as Q)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz